p53 upregulates death receptor 4 expression through an intronic p53 binding site

被引:147
|
作者
Liu, XG [1 ]
Yue, P [1 ]
Khuri, FR [1 ]
Sun, SY [1 ]
机构
[1] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA
关键词
D O I
10.1158/0008-5472.CAN-04-1195
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Death receptor 4 (DR4) is one of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors and triggers apoptosis on ligation with TRAIL or overexpression. Our previous study demonstrated that DR4 expression could be regulated in a p53-dependent fashion. In the present study, we have demonstrated that DR4 is a p53 target gene and is regulated by p53 through a functional intronic p53 binding site (p53BS) based on the following lines of evidence: (a) the p53BS in the DR4 gene is almost identical to the one found in the first intron of the DR5 gene in terms of their locations and sequences; (b) DR4 p53BS bound to p53 protein in intact cells upon p53 activation as demonstrated by a chromatin immunoprecipitation assay; (c) a luciferase reporter vector carrying the DR4 p53BS upstream of an SV40 promoter exhibited enhanced luciferase activity when transiently cotransfected with a wild-type p53 expression vector in p53-null cell lines or stimulated with DNA-damaging agents in a cell line having wild-type p53; and (d) when the DR4 p53BS, together with its own corresponding promoter region in the same orientation as it sits in its natural genomic locus, was cloned into a basic luciferase vector without a promoter element, its transcriptional activity was strikingly increased by cotransfection of a wild-type p53 expression vector or treatment with DNA-damaging agents. However, wild-type p53 or DNA-damaging agents completely lost their activity to increase transcriptional activity of a reporter construct with deleted DR4 p53BS. Thus, we conclude that p53 directly regulates the expression of the DR4 gene via the novel intronic p53BS.
引用
收藏
页码:5078 / 5083
页数:6
相关论文
共 50 条
  • [1] Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site
    Tasheva, ES
    Maki, CG
    Conrad, AH
    Conrad, GW
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2001, 1517 (03): : 333 - 338
  • [2] Understanding p53 functions through p53 antibodies
    Sabapathy, Kanaga
    Lane, David P.
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (04) : 317 - 329
  • [3] The intronic p53-binding site is essential for activation of the CD95 gene by the p53 family network
    Schleithoff, Elisa Schulze
    Kairat, Astrid
    Koch, Andreas
    Schilling, Tobias
    Li-Weber, Min
    Krammer, Peter H.
    Mueller, Martina
    HEPATOLOGY, 2007, 46 (04) : 523A - 524A
  • [4] p53 transactivates the phosphatase MKP1 through both intronic and exonic p53 responsive elements
    Yang, HJ
    Wu, GS
    CANCER BIOLOGY & THERAPY, 2004, 3 (12) : 1277 - 1282
  • [5] TRANSACTIVATION OF P53 THROUGH VARIOUS P53 RESPONSIVE ELEMENTS
    PARK, DJ
    CHUMAKOV, AM
    KOEFFLER, HP
    BLOOD, 1993, 82 (10) : A530 - A530
  • [6] p53: Death star
    Vousden, KH
    CELL, 2000, 103 (05) : 691 - 694
  • [7] LIFE AND DEATH BY P53
    ELLEDGE, RM
    LEE, WH
    BIOESSAYS, 1995, 17 (11) : 923 - 930
  • [8] p53 in life and death
    Shimamura, A
    Fisher, DE
    CLINICAL CANCER RESEARCH, 1996, 2 (03) : 435 - 440
  • [9] Living with p53, dying of p53
    Aylon, Yael
    Oren, Moshe
    CELL, 2007, 130 (04) : 597 - 600
  • [10] ACETYLATION OF THE p53 CTD ABOLISHES SET BINDING TO ACTIVATE p53
    不详
    CANCER DISCOVERY, 2016, 6 (11) : 1208 - 1208